Faigel D O, Metz D C
Department of Internal Medicine, University of Pennsylvania, Philadelphia 19104, USA.
Dig Dis Sci. 1996 Jan;41(1):1-8. doi: 10.1007/BF02208576.
We reviewed the discharge records of all diabetic ketoacidosis hospitalizations over 30 months for the presence of clinically significant upper gastrointestinal hemorrhage. Of 284 hospitalizations in 193 patients, hemorrhage occurred in 26 hospitalizations (9%) in 25 patients (13%). None required invasive therapy to achieve hemostasis, and there were no bleeding recurrences and no deaths due to bleeding. Endoscopy in eight revealed esophagitis in all (five had erosions or ulcerations), one Mallory-Weiss tear, five with gastritis (mild in four), four with duodenitis (one erosive), one duodenal ulcer, and no gastric ulcers. Hemorrhage patients had a longer diabetes duration (14.85 vs 9.16 years, P < 0.02), and more nephropathy (40% vs 11%, P < 0.001), retinopathy (28% vs 12%, P < 0.03) and gastroparesis (36% vs 10%, P < 0.002) than those without hemorrhage. Ulcer medication (42% vs 23%, P < 0.03) or anticoagulant (12% vs 1%, P < 0.005) but not nonsteroidal antiinflammatory drug usage (12% vs 12%) was higher in the hemorrhage group. Admission glucose (P < 0.02), BUN (P < 0.04), and creatinine (P < 0.02) levels were higher in hemorrhage patients, but arterial pH, serum ketones, hemoglobin, platelet count, and coagulation values were not. Hemorrhage patients required more blood transfusions (27% vs 10%, P < 0.003) and intensive care unit admissions (69% vs 43%, P < 0.009). Total (15% vs 3%, P < 0.003) and intensive care unit mortality (22% vs 6%, P < 0.026) were higher in the hemorrhage group. We conclude that upper gastrointestinal hemorrhage complicates 9% of diabetic ketoacidosis hospitalizations. Blood transfusion may be required, but the bleeding is self-limited and not severe. The most common lesion is erosive esophagitis. Hemorrhage correlates with glucose level, admission to the intensive care unit, duration of diabetes, the presence of diabetic complications, and portends a high non-bleeding-related mortality.
我们回顾了30个月内所有糖尿病酮症酸中毒住院患者的出院记录,以确定是否存在具有临床意义的上消化道出血。在193例患者的284次住院治疗中,25例患者(13%)的26次住院(9%)发生了出血。无一例需要侵入性治疗来实现止血,且无出血复发,也没有因出血导致的死亡。8例患者接受内镜检查,结果显示均有食管炎(5例有糜烂或溃疡)、1例马洛里-魏斯撕裂、5例胃炎(4例为轻度)、4例十二指肠炎(1例糜烂)、1例十二指肠溃疡,无胃溃疡。与未出血患者相比,出血患者的糖尿病病程更长(14.85年对9.16年,P<0.02),肾病(40%对11%,P<0.001)、视网膜病变(28%对12%,P<0.03)和胃轻瘫(36%对10%,P<0.002)更多。出血组使用溃疡药物(42%对23%,P<0.03)或抗凝剂(12%对1%,P<0.005)的比例更高,但使用非甾体抗炎药的比例(12%对12%)无差异。出血患者的入院血糖(P<0.02)、血尿素氮(P<0.04)和肌酐(P<0.02)水平较高,但动脉pH值、血清酮体、血红蛋白、血小板计数和凝血指标无差异。出血患者需要更多的输血(27%对10%,P<0.003)和入住重症监护病房(69%对43%,P<0.009)。出血组的总死亡率(15%对3%,P<0.003)和重症监护病房死亡率(22%对6%,P<0.026)更高。我们得出结论,上消化道出血使9%的糖尿病酮症酸中毒住院患者病情复杂化。可能需要输血,但出血是自限性的,并不严重。最常见的病变是糜烂性食管炎。出血与血糖水平、入住重症监护病房、糖尿病病程、糖尿病并发症的存在相关,且预示着较高的非出血相关死亡率。